Physician profile
Christopher Cappellini
NPI 1215477658
$11,593.95
in general payments reported to CMS, 2019-2025
15 companies · $2,359 in 2025
The $2,359 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $318 · 2021: $364 · 2022: $5,532 · 2023: $1,058 · 2024: $1,963 · 2025: $2,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,019 · Education: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,019.45 |
| Education | $360.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,264.60 | 2021-2025 | Endurant Iis, Heli-Fx Endoanchor System |
| Boston Scientific Corporation | $2,283.21 | 2021-2025 | General - Non-Vascular Intervention, General - Angiography, Jetstream Sc |
| W. L. Gore & Associates, INC. | $560.02 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Inari Medical, INC. | $361.16 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $318.00 | 2020 | |
| Silk Road Medical, INC. | $204.02 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $186.08 | 2024 | Zenith, Zenith Spiral-Z |
| Penumbra, INC. | $124.29 | 2025 | Indigo System |
| Kerecis Limited | $104.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Shockwave Medical, INC | $68.67 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lemaitre Vascular, INC. | $28.46 | 2025 | Artegraft Vascular Graft |
| Cagent Vascular INC | $25.00 | 2024 | Serrantor |
| Cvrx, INC. | $25.00 | 2025 | Barostim Neo System |
| Solventum Corporation | $23.58 | 2025 | Prevena, V.A.C.Instill, V.A.C.Ulta |
| Davol INC. | $17.43 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cappellini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.